Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Validation of Virtual Reality Tests for the Assessment of Patients With Age-related Macular Degeneration
Authors not listed
Streetlab · 2026
Abstract
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in industrialized countries and affects tens of millions of people worldwide, with a rapidly increasing prevalence. It causes irreversible central vision loss and significant difficulties in daily activities, impairing patients' quality of life and independence. Conventional clinical assessments, which focus on visual acuity and retinal imaging, do not fully reflect the functional impact of the disease.
Virtual reality (VR) makes it possible to create immersive, controlled environments to accurately measure functional vision and simulate real-life situations. The study proposes to develop a standardized and reproducible functional test in virtual reality that can complement conventional examinations and support clinical and industrial research.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Anonymous. (2026). Validation of Virtual Reality Tests for the Assessment of Patients With Age-related Macular Degeneration. <em>Streetlab</em>. https://clinicaltrials.gov/study/NCT07433088
Vancouver
Anonymous. Validation of Virtual Reality Tests for the Assessment of Patients With Age-related Macular Degeneration. Streetlab. 2026.
BibTeX
@misc{anon2026Valida,
title = {Validation of Virtual Reality Tests for the Assessment of Patients With Age-related Macular Degeneration},
author = {Anonymous},
journal = {Streetlab},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PubMed 1996
Preprint
Oral zinc and the second eye in age-related macular degeneration.
Genaera Corporation 2004
Open access · US-GOV
A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration
American Journal of Ophthalmology 1995
Citation only
A Twin Study of Age-related Macular Degeneration
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 2024
Open access · US-GOV
Validation of Standardized Tasks and Questionnaires to Evaluate and Understand the Impact of Age-related Macular Degeneration on Daily Living Activitie
Neurobiology of Aging 2005
Citation only
Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration
Ophthalmology 2006
Citation only